These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16238959)

  • 1. [Venous thromboembolism and hyperhomocysteinemia as first manifestation of pernicious anemia].
    Fernández-Miranda C; Yebra Yebra M; Ribera Casado C; Toledo Urgarte T; Martín Mola M; Gómez González P
    Rev Clin Esp; 2005 Oct; 205(10):489-92. PubMed ID: 16238959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thromboembolism and hyperhomocysteinemia as first manifestation of pernicious anemia: a case series.
    Ammouri W; Tazi ZM; Harmouche H; Maamar M; Adnaoui M
    J Med Case Rep; 2017 Sep; 11(1):250. PubMed ID: 28863787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biermer's disease and venous thrombosis. Report of two cases].
    Kharchafi A; Oualim Z; Amezyane T; Mahassin F; Ghafir D; Ohayon V; Archane MI
    Rev Med Interne; 2002 Jun; 23(6):563-6. PubMed ID: 12108182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thrombosis associated with pernicious anaemia. A report of two cases and review.
    Barrios M; Alliot C
    Hematology; 2006 Apr; 11(2):135-8. PubMed ID: 16753856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portal, superior mesenteric and splenic vein thrombosis secondary to hyperhomocysteinemia with pernicious anemia: a case report.
    Venkatesh P; Shaikh N; Malmstrom MF; Kumar VR; Nour B
    J Med Case Rep; 2014 Aug; 8():286. PubMed ID: 25155131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhomocysteinemia due to pernicious anemia leading to pulmonary thromboembolism in a heterozygous mutation carrier.
    Küpeli E; Cengiz C; Cila A; Karnak D
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):365-8. PubMed ID: 18586684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pernicious anaemia: cause of recurrent cerebral venous thrombosis.
    Prajapati K; Sailor V; Patel S; Rathod M
    BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 33972295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary embolism in pernicious anemia and hyperhomocysteinemia.
    Andrès E; Kurtz JE
    Chest; 2003 Sep; 124(3):1181. PubMed ID: 12970061
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vitamin B12 deficiency-induced moderate hyperhomocysteinemia and venous thromboembolism].
    Andres E; Perrin AE; Noel E; Schlienger JL; Blickle JF; Brogard JM
    Ann Med Interne (Paris); 2002 Nov; 153(7):483-4. PubMed ID: 12598836
    [No Abstract]   [Full Text] [Related]  

  • 10. [Thromboembolic event and metabolic hyperhomocysteinemia: A case report and review of literature].
    Biron F; Rousseau JF; Baulin JM; Guérin-Boyer M; Lanéelle D
    Ann Cardiol Angeiol (Paris); 2021 Jun; 70(3):177-182. PubMed ID: 33962786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism.
    Eichinger S; Stümpflen A; Hirschl M; Bialonczyk C; Herkner K; Stain M; Schneider B; Pabinger I; Lechner K; Kyrle PA
    Thromb Haemost; 1998 Oct; 80(4):566-9. PubMed ID: 9798970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary embolism in a patient with pernicious anemia and hyperhomocysteinemia.
    Caldera A; Mora J; Kotler M; Eiger G
    Chest; 2002 Oct; 122(4):1487-8. PubMed ID: 12377886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuropsychiatric manifestations ushering pernicious anemia].
    Mrabet S; Ellouze F; Ellini S; Mrad MF
    Encephale; 2015 Dec; 41(6):550-5. PubMed ID: 26345354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocysteine-lowering therapy and risk for venous thromboembolism: a randomized trial.
    Ray JG; Kearon C; Yi Q; Sheridan P; Lonn E;
    Ann Intern Med; 2007 Jun; 146(11):761-7. PubMed ID: 17470822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperhomocysteinemia: clinical and therapeutical involvement in venous thrombosis.
    Hoţoleanu C; Porojan-Iuga M; Rusu ML; Andercou A
    Rom J Intern Med; 2007; 45(2):159-64. PubMed ID: 18333369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
    Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
    J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hyperhomocysteinemia in vascular disease: comparative study of thrombotic venous disease vis-à-vis occlusive arterial disease.
    Bhargava S; Parakh R; Manocha A; Ali A; Srivastava LM
    Vascular; 2007; 15(3):149-53. PubMed ID: 17573020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ischemic, an uncommon complication of Biermer disease (pernicious anemia)].
    Leemann B; Boughanem N; Schnider A
    Rev Neurol (Paris); 2006 Oct; 162(10):1007-10. PubMed ID: 17028570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenteric venous thrombosis revealing both factor II G20212A mutation and hyperhomocysteinemia related to pernicious anemia.
    Marie I; Levesque H; Le Cam-Duchez V; Borg JY; Ducrotté P; Philippe C
    Gastroenterology; 2000 Jan; 118(1):237-8. PubMed ID: 10644179
    [No Abstract]   [Full Text] [Related]  

  • 20. Reliability of the dual-isotope Schilling test for the diagnosis of pernicious anemia or malabsorption syndrome.
    Domstad PA; Choy YC; Kim EE; DeLand FH
    Am J Clin Pathol; 1981 May; 75(5):723-6. PubMed ID: 7234758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.